| 000 | 01810 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250514045721.0 | ||
| 264 | 0 | _c20030131 | |
| 008 | 200301s 0 0 eng d | ||
| 022 | _a1027-3719 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMigliori, G B | |
| 245 | 0 | 0 |
_aFrequency of recurrence among MDR-tB cases 'successfully' treated with standardised short-course chemotherapy. _h[electronic resource] |
| 260 |
_bThe international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease _cOct 2002 |
||
| 300 |
_a858-64 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAntibiotics, Antitubercular _xadministration & dosage |
| 650 | 0 | 4 |
_aAntitubercular Agents _xadministration & dosage |
| 650 | 0 | 4 | _aDrug Administration Schedule |
| 650 | 0 | 4 | _aDrug Combinations |
| 650 | 0 | 4 |
_aEthambutol _xadministration & dosage |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aIsoniazid _xadministration & dosage |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aPyrazinamide _xadministration & dosage |
| 650 | 0 | 4 | _aRecurrence |
| 650 | 0 | 4 |
_aRifampin _xadministration & dosage |
| 650 | 0 | 4 |
_aRussia _xepidemiology |
| 650 | 0 | 4 |
_aStreptomycin _xadministration & dosage |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 | _aTreatment Failure |
| 650 | 0 | 4 |
_aTuberculosis, Multidrug-Resistant _xdrug therapy |
| 700 | 1 | _aEspinal, M | |
| 700 | 1 | _aDanilova, I D | |
| 700 | 1 | _aPunga, V V | |
| 700 | 1 | _aGrzemska, M | |
| 700 | 1 | _aRaviglione, M C | |
| 773 | 0 |
_tThe international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease _gvol. 6 _gno. 10 _gp. 858-64 |
|
| 999 |
_c12176594 _d12176594 |
||